Multi-omics revealed that the effects of SCU on liver fibrosis are multi-target and multi-level; whether SCU mediates its anti-liver-fibrosis effect by regulating the intestinal flora–metabolite network to inhibit the PI3K/AKT pathway remains to be further explored. This evidence concerns the gene AKT1 and Hepatic fibrosis.